Shlomo Melmed

Shlomo Melmed is a Professor-in-Residence in the Department of Medicine at the UCLA School of Medicine. His work focuses on neuroendocrine disorders, particularly pituitary adenomas, acromegaly, and hormone regulation. He is actively involved in international consensus efforts to standardize the classification and management of pituitary diseases.

Dr. Melmed's research spans molecular mechanisms of pituitary tumorigenesis, clinical therapeutics for acromegaly, and innovative treatments for Cushing's disease. His recent investigations emphasize targeted drug delivery, tumor microenvironment interactions, and refining diagnostic criteria for endocrine disorders.

Analysis of his 15 most recent publications (2021–2025) reveals a predominant focus on pituitary neoplasms, including surgical guidelines, pharmacotherapy innovations (e.g., oral octreotide), and molecular pathways in hormone secretion. His work frequently contributes to international consensus statements and clinical classification systems.

No awards, students, or lab affiliations are detailed in the source material.